RDHL
Redhill Biopharma
RDHL
RDHL
37 hedge funds and large institutions have $1.51M invested in Redhill Biopharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
37
Holding in Top 10
–
Calls
$14K
Puts
$2K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$286K | |
| 3 | +$151K | |
| 4 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
+$57.6K |
| 5 |
Morgan Stanley
New York
|
+$25.1K |
Top Sellers
| 1 | -$171K | |
| 2 | -$82K | |
| 3 | -$41.1K | |
| 4 |
VF
Virtu Financial
New York
|
-$31K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$23.8K |